SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-252087
Filing Date
2017-08-09
Accepted
2017-08-09 07:38:56
Documents
3
Period of Report
2017-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d409412d8k.htm 8-K 21823
2 EX-10.1 d409412dex101.htm EX-10.1 173434
3 EX-10.2 d409412dex102.htm EX-10.2 63730
  Complete submission text file 0001193125-17-252087.txt   260185
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 171016464
SIC: 2834 Pharmaceutical Preparations